Trade Victrex PLC - VCTl CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.0282
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment£1,000.00Overnight funding adjustmentCharges from full value of position-0.021269 %(-£4.25)Trade size with leverage ~ £20,000.00Money from leverage ~ $£19,000.00Go to platform: -0.02127%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment£1,000.00Overnight funding adjustmentCharges from full value of position-0.000649 %(-£0.13)Trade size with leverage ~ £20,000.00Money from leverage ~ $£19,000.00Go to platform: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: GBP
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: Great Britain
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: £1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021269 %
  (-£4.25)

• Margin. Your investment: £1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000649 %
  (-£0.13)

Key Stats

• Prev. Close: 8.961
• Open: 9.1008
• 1-Year Change: 33.05%
• Day's Range: 8.881 - 9.1008

Trade Victrex PLC - VCTl

About Victrex plc

Victrex plc is a United Kingdom-based polymer solutions company. The Company is focused on markets of automotive, aerospace, energy, (including manufacturing and engineering), electronics and medical. It operates through two segments: Industrial and Medical. The Industrial segment focuses on its energy and industrial, value added resellers (var), automotive, aerospace and electronics markets. The Medical segment focuses on providing specialist solutions for medical device manufacturers. The Company develops solutions in polyetheretherketone (PEEK) and polyaryletherketone (PAEK) based polymers, and selected semi-finished and finished parts. The Company serves in more than 40 countries across the world having geographical locations in the United Kingdom; Europe, Middle East and Africa (EMEA); Americas, and Asia-Pacific.

Financial summary

BRIEF: For the fiscal year ended 30 September 2021, Victrex plc revenues increased 18% to £311.2M. Net income increased 35% to £73.2M. Revenues reflect Industrial segment increase of 18% to £255.2M, Medical segment increase of 3% to £51.1M, Europe, Middle East and Africa(EMEA) segment increase of 23% to £139.3M, Asia-Pacific segment increase of 15% to £85.9M. Net income benefited from Restructuring costs decrease from £9.8M (expense) to £800K (income).